Ascendient Capital's Analyst Stock Recommendations
Analyst recommendations > Ascendient Capital recommendations for NASDAQ, NYSE, and NYSEMKT stocks

Company Date Change Recommendation
GALT Galectin Therapeutics Inc. 6 October 2013 Buy